Related Experiment Video
Updated: Mar 10, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating
Objective:
Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been well studied in the progression of many malignancies. However, its association with the radioresistance of tumors has not been well understood yet. This study tried to explore the role of MALAT1 in regulating the radiosensitivity of esophageal cancer (EC), especially esophageal squamous cell carcinoma (ESCC), involving its regulation on Cks1 expression.
Methods:
KYSE150 cells were subcutaneously inoculated into nude mice to establish ESCC xenografts. Real-time PCR and Western blot analysis were performed to detect the expression of MALAT1 and Cks1 in irradiated xenografts and cells. Functional analysis was performed in both EC9706 and KYSE150 cells via the transfection of corresponding plasmids or small interfering RNAs (siRNAs). Irradiation-induced damage was examined by the detection of cell viability and apoptosis using MTT and TUNEL assays, respectively.
Results:
Both MALAT1 and Cks1 were downregulated in irradiated xenografts and cells. Cks1FER1L4 showed significant downregulation. Overexpression of MALAT1 inhibited irradiation-induced decrease in cell viability, increase in apoptosis, and downregulation of Cks1. Cks1 expression was also downregulated by MALAT1 siRNA, while Cks1 siRNA strongly recovered MALAT1-induced radioresistance in vitro. Moreover, better tumor growth, accompanied by Cks1 upregulation, was observed in KYSE150 xenografts with MALAT1 overexpression, especially under radiation treatment.
Conclusion:
MALAT1 acted as one positive regulator of the radioresistance of ESCC, at least partly due to its promotion on Cks1 expression. Furthermore, MALAT1-targeted therapies showed great potential in enhancing the radiotherapeutic effect on ESCC.
Insights
Long noncoding RNA MALAT1 promotes radioresistance in esophageal squamous cell carcinoma by upregulating Cks1. Targeting MALAT1 may enhance radiotherapy effectiveness for ESCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is implicated in various cancers.
- The role of MALAT1 in tumor radioresistance, particularly in esophageal cancer, remains unclear.
- Understanding MALAT1's function is crucial for improving esophageal squamous cell carcinoma (ESCC) treatment.
Purpose of the Study:
- To investigate the role of MALAT1 in regulating radiosensitivity in esophageal cancer (EC), specifically ESCC.
- To explore the underlying mechanism involving Cks1 expression.
- To assess the therapeutic potential of targeting MALAT1 in ESCC.
Main Methods:
- Establishment of ESCC xenografts in nude mice.
- Quantitative real-time PCR and Western blot to assess MALAT1 and Cks1 expression.
- In vitro functional assays using cell transfection with plasmids or siRNAs for MALAT1 and Cks1.
- Evaluation of cell viability (MTT assay) and apoptosis (TUNEL assay) after irradiation.
Main Results:
- Both MALAT1 and Cks1 expression decreased upon irradiation in xenografts and cells.
- Overexpression of MALAT1 enhanced radioresistance by inhibiting irradiation-induced apoptosis and promoting cell viability, while downregulating Cks1.
- MALAT1 siRNA reduced radioresistance, and Cks1 siRNA reversed MALAT1-induced radioresistance.
- Tumor growth was enhanced with MALAT1 overexpression, along with Cks1 upregulation, especially under radiation.
Conclusions:
- MALAT1 positively regulates radioresistance in ESCC, partly by promoting Cks1 expression.
- Targeting MALAT1 presents a promising strategy to enhance the efficacy of radiotherapy for ESCC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
RNA Splicing
Non-LTR Retrotransposons
